Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report.
Hum Vaccin Immunother
; 18(6): 2121109, 2022 Nov 30.
Article
in En
| MEDLINE
| ID: mdl-36166751
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Esophageal Neoplasms
Limits:
Aged
/
Humans
/
Male
Language:
En
Journal:
Hum Vaccin Immunother
Year:
2022
Document type:
Article
Affiliation country: